Alkem launches inhalation device Innohaler for COPD patients
03 May 2022 | News
With the introduction of this device, Alkem is entering the core inhalation therapeutics
Mumbai-based Alkem Laboratories has launched Innohaler, a DPI device to make life easier for Asthma and COPD (Chronic Obstructive Pulmonary Disease) patients.
A Dry Powder Inhaler (DPI) is considered the most preferred drug delivery platform for such patients. Alkem is all set to fill the massive gap in accessibility for treating of respiratory diseases in India and has further made a big leap in the pulmonology vertical by introducing Innohaler, a DPI device.
With the introduction of this device, Alkem is entering the core inhalation therapeutics and envisaging that the drug will reach the lungs effectively in each inhalation with added patient awareness and adherence programmes.
